Body Mass Index: Clinical Guide

Overview

Body mass index, usually abbreviated to BMI, expresses body weight relative to height. It is calculated by dividing weight in kilograms by height in metres squared. BMI is widely used as an initial screening measure because it is quick, inexpensive and reproducible.

Clinical Significance

BMI categories are associated at population level with differences in the likelihood of obesity-related disease, nutritional risk and mortality. For an individual patient, BMI does not directly measure body fat, fat distribution, muscle mass or metabolic health and should not be interpreted in isolation.

When to Use

• Use as an initial adult weight-status screening measure.
• Use when assessing possible underweight, overweight or obesity.
• Use as part of cardiovascular, metabolic, nutritional or perioperative assessment.
• Interpret with waist-to-height ratio or another measure of central adiposity when clinically appropriate.
• Use an age-appropriate centile-based method rather than adult thresholds for children and young people.

How It Is Calculated

• Convert height to metres.
• Square the height in metres.
• Divide weight in kilograms by height in metres squared.
• Formula: BMI = weight in kg ÷ height in metres².
• The result is expressed in kg/m².

Interpretation

• Below 18.5 kg/m²: underweight.
• 18.5 to 24.9 kg/m²: healthy weight range.
• 25.0 to 29.9 kg/m²: overweight.
• 30.0 to 34.9 kg/m²: obesity class 1.
• 35.0 to 39.9 kg/m²: obesity class 2.
• 40.0 kg/m² or above: obesity class 3.
• Category thresholds should be interpreted with the patient’s ethnicity, age, muscle mass, central adiposity, health conditions and clinical circumstances.

Worked Example

An adult weighing 80 kg with a height of 1.80 metres has a BMI of 80 ÷ (1.80 × 1.80), giving a result of approximately 24.7 kg/m². This lies within the standard adult healthy weight range.

Patient Considerations

• BMI may overestimate adiposity in people with high muscle mass.
• BMI may underestimate risk when excess fat is concentrated centrally despite a BMI below the obesity threshold.
• Different thresholds or additional assessment may be appropriate for some ethnic groups because cardiometabolic risk can occur at a lower BMI.
• Older adults may have reduced muscle mass despite a BMI within the standard healthy range.
• Pregnancy, oedema, ascites, amputation and major changes in hydration can make BMI difficult to interpret.
• BMI categories for children and young people require age- and sex-specific centiles.

Limitations

• BMI does not distinguish fat mass from muscle, bone or fluid.
• BMI does not show where body fat is distributed.
• It does not directly measure metabolic health or cardiovascular risk.
• A single measurement does not show the direction or speed of weight change.
• Standard adult categories may not reflect equivalent risk across all ethnic groups.
• BMI should not replace clinical history, physical examination, laboratory assessment or evaluation of comorbidities.

Clinical Pearls

• Review the trend in weight and BMI rather than relying only on one measurement.
• Consider waist-to-height ratio or waist circumference when assessing central adiposity.
• Investigate unintentional weight loss even when the resulting BMI remains within the standard healthy range.
• Consider sarcopenia and nutritional status separately, particularly in older or chronically ill adults.
• Use respectful, person-centred language when discussing body weight.

Common Mistakes

• Using adult BMI thresholds for children or adolescents.
• Treating BMI as a direct measurement of body fat percentage.
• Ignoring high muscle mass, oedema, ascites, pregnancy or amputation.
• Entering centimetres as metres or selecting the wrong weight unit.
• Assuming that a BMI within the healthy range excludes metabolic or nutritional risk.
• Making treatment decisions from BMI alone without assessing the wider clinical context.

Evidence Base

BMI is an established anthropometric index used internationally for adult weight classification and population surveillance. Current clinical guidance retains BMI as an initial assessment measure but recommends interpreting it alongside central adiposity, comorbidities and individual clinical factors.

References

1. NICE. Overweight and obesity management. NICE guideline NG246. — Current UK guidance on identifying, assessing and managing overweight, obesity and central adiposity.
2. NICE. Identifying and assessing overweight, obesity and central adiposity. — Adult BMI classification and recommendations on interpretation.
3. World Health Organization. Body mass index among adults. — International definitions and population indicators for adult BMI.
4. Centers for Disease Control and Prevention. About Body Mass Index. — Overview of BMI as a screening and population-health measure.